Home » Newsletters » BioWorld

BioWorld

Feb. 25, 1992

View Archived Issues

TSI SHARES ELIGIBLE FOR CONVERSION

CAMBRIDGE BIO ENTERS PRIVATE LABEL PACT

ONCOTECH TO DEVELOP IMUVERT

CIBA TO TEST APHTON IMMUNE STIMULANTS

MEDICIS WARRANT REDEMPTION RAISES $14M

MYCOGEN ADOPTS POISON PILL

SOMATOGEN BLOOD SUBSTITUTE ENTERS TRIALS

ICOS BACK TO THE FUNDING WELL

GRANT FOR DNA IDENTIFICATION SYSTEM

MGI FILES FOR SALAGEN APPROVAL

RISK POLICY PAVES WAY FOR BIOTECH RULES

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 13, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026